ARAP3 and breast carcinoma: In addition, we found that a cancer-associate point mutation within the Arap3-PH1 domain (R308H) abolishes its binding to PI(3,4,5)P3 lipid, and impairs the capacity of Arap3 to inhibit breast cancer cell invasion in vitro.